Natural product therapy for pulmonary arterial hypertension: α-Linoleic acid, isolated from Flax seeds, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 1/January/2018, 5.41 am

Natural product-based therapy for Diabetic retinopathy: A pharmaceutical mixture encompassing  α-linoleic acid, Epicatechin and Matrine (LAEM)  inhibits Soluble epoxide hydrolase (sEH) expression, decreases toxic 19,20-dihydroxydocosapentaenoic acid levels, inhibits pericyte loss, vascular permeability, and inflammation of the eye and progression of diabetic retinopathy, via down regulation of its target gene, 1/January/2018, 5.23 am
December 31, 2017
Molecular therapy for inflammation and arthritis: A pharmaceutical mixture encompassing Calcitriol and  TNF-α (CAT)  increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up-regulation of its target genes, 1/January/2018, 8.46 am
January 1, 2018
Show all

What they say: 

A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.”
This study was published, in the 15 November  2009 issue of the journal “Nature Medicine”[the number 1 journal in General Medicine with an I.F of 28.054], by Prof. Thistlethwaite PA, Li X and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:   Natural product therapy for pulmonary arterial hypertension: Glycyrrhetinic acid, isolated from Licorice, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3


Significance of the study:  

α-Linoleic acidby increasing the expression of its target gene, it may decrease the expression of Notch3 and its target gene Hes-5 (Fig.1). 

Figure 1. Mechanistic insights into how  inhibits the development of pulmonary hypertension. α-Linoleic acid, by inhibiting Notch-3 and its target gene Hes-5, functions as an anti-hypertensive agent.

Figure 2. The chemical structure of α-Linoleic acid and the source from which it can be derived is indicated above.

Thus, pharmacological formulations encompassing “α-Linoleic acid or its analogues, either alone or in combination with other drugs, may be used to treat pulmonary arterial hypertension.


Details of the research findings: 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Undisclosed mechanistic information: How α-Linoleic acid  decreases the expression of Notch3 

Amount: $100#

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

For purchase and payment details, you may reach us at info@genomediscovery.org

# Research cooperation


References: 

Web: http://genomediscovery.org or http://newbioideas.com/

CitationBoominathan, L.,  Natural product therapy for pulmonary arterial hypertension: α-Linoleic acid, isolated from Flax seeds, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 1/January/2018, 5.41 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite us, drop us a line at info@genomediscovery.org

Comments are closed.